Cargando…

Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis

Amyloid is a complex pathologic matrix comprised principally of paracrystalline protein fibrils and heparan sulfate proteoglycans. Systemic amyloid diseases are rare, thus, routine diagnosis is often challenging. The glycosaminoglycans ubiquitously present in amyloid deposits are biochemically and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wall, Jonathan S., Martin, Emily B., Richey, Tina, Stuckey, Alan C., Macy, Sallie, Wooliver, Craig, Williams, Angela, Foster, James S., McWilliams-Koeppen, Penney, Uberbacher, Ed, Cheng, Xiaolin, Kennel, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442108/ https://www.ncbi.nlm.nih.gov/pubmed/25923515 http://dx.doi.org/10.3390/molecules20057657

Ejemplares similares

A Peptide-Fc Opsonin with Pan-Amyloid Reactivity
por: Foster, James S., et al.
Publicado: (2017)

Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide (124)I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging
por: Martin, Emily B., et al.
Publicado: (2023)

Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion
por: Foster, James S., et al.
Publicado: (2023)

Evaluation of the effect of d-amino acid incorporation into amyloid-reactive peptides
por: Martin, Emily B., et al.
Publicado: (2017)

A Binding-Site Barrier Affects Imaging Efficiency of High Affinity Amyloid-Reactive Peptide Radiotracers In Vivo
por: Wall, Jonathan S., et al.
Publicado: (2013)

Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes
por: McWilliams-Koeppen, Helen P., et al.
Publicado: (2015)

Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis
por: Martin, Emily B., et al.
Publicado: (2016)

AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils
por: Wall, Jonathan S., et al.
Publicado: (2012)

Generation and Characterization of Anti-AA Amyloid-Specific Monoclonal Antibodies
por: Wall, Jonathan S., et al.
Publicado: (2011)

Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding - In vitro characterization
por: Wall, Jonathan S., et al.
Publicado: (2016)

Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis
por: Wall, Jonathan S., et al.
Publicado: (2017)

Heparin-resistance in AL amyloidosis: a case report
por: van Ede, Elisabeth S., et al.
Publicado: (2023)

Characterization of X-ray Dose in Murine Animals Using microCT, a New Low-Dose Detector and nanoDot Dosimeters
por: Osborne, Dustin R., et al.
Publicado: (2012)

Preclinical Models of Visceral Sarcomas
por: Costa, Alice, et al.
Publicado: (2023)

Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
por: Butler, James S., et al.
Publicado: (2016)

A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir
por: Osborne, Dustin R., et al.
Publicado: (2015)

Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils—A metric for predicting amyloid propensity
por: Martin, Emily B., et al.
Publicado: (2017)

Preclinical Development of siRNA Therapeutics for AL Amyloidosis
por: Hovey, Beth M., et al.
Publicado: (2011)

Heparin in malignant glioma: review of preclinical studies and clinical results
por: Schnoor, Rosalie, et al.
Publicado: (2015)

Preclinical Study of DCD and Normothermic Perfusion for Visceral Transplantation
por: Serradilla, Javier, et al.
Publicado: (2023)

DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
por: Mowbray, Charles E., et al.
Publicado: (2021)

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
por: Wyllie, Susan, et al.
Publicado: (2019)

Blood-based microRNA profiling in patients with cardiac amyloidosis
por: Derda, Anselm A., et al.
Publicado: (2018)

Systemic administration of heparin ameliorates radiation-induced oral mucositis—preclinical studies in mice
por: Kowaliuk, Maria, et al.
Publicado: (2018)

Correct Patterning of the Primitive Streak Requires the Anterior Visceral Endoderm
por: Stuckey, Daniel W., et al.
Publicado: (2011)

Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
por: Viney, Nicholas J., et al.
Publicado: (2020)

Anti-amyloidogenic Activity of IgGs Contained in Normal Plasma
por: O’Nuallain, Brian, et al.
Publicado: (2010)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
por: Williams, Jonathan S., et al.
Publicado: (2018)

Novel Heparan Sulfate-Binding Peptides for Blocking Herpesvirus Entry
por: Dogra, Pranay, et al.
Publicado: (2015)

Engineered heparins as new anticoagulant drugs
por: Vaidyanathan, Deepika, et al.
Publicado: (2016)

Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies
por: KARIYAWASAM, K. K. G. D. U. L., et al.
Publicado: (2018)

Characterising the incidence and mode of visceral stent failure after fenestrated endovascular aneurysm repair (FEVAR)
por: Patel, Shaneel R, et al.
Publicado: (2021)

Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice
por: Bruckbauer, Antje, et al.
Publicado: (2012)

hMPV Lineage Nomenclature and Heparin Binding
por: Adamson, Penelope, et al.
Publicado: (2013)

IgG Conformer's Binding to Amyloidogenic Aggregates
por: Phay, Monichan, et al.
Publicado: (2015)

Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis
por: Jesus, Jéssica Adriana, et al.
Publicado: (2021)

Massive Hepatomegaly Secondary to Amyloidosis with Normal Liver Chemistries
por: Doe-Williams, Sarah, et al.
Publicado: (2020)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
por: Lane, T, et al.
Publicado: (2013)

Preparation, Properties and Preclinical Pharmacokinetics of Low Molecular Weight Heparin-modified Isoliquiritigenin-loaded Solid Lipid Nanoparticle
por: Zhang, Xiaoyun, et al.
Publicado: (2016)

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
por: Thomas, Michael G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ml95f4e4q3e7k23ompbsr9otak